日本的足部·腳踝用設備市場:各產品，手藝，各用途，各地區，機會，預測，2018年～2032年

2025-2032年預測期內，日本足部和腳踝裝置市場規模將以8.55%的複合年增長率增長，從2024年的2.2437億美元增長到2032年的4.3253億美元，預計將增長至1000萬美元。由於老年人口的增加、微創手術的需求增加以及醫療保健技術的不斷進步，預計日本的足部和腳踝設備市場將在預測期內強勁增長。

日本的足部和腳踝裝置市場受到糖尿病相關併發症、骨質疏鬆症和運動傷害等疾病高發生率的嚴重影響。糖尿病週邊神經病變影響相當多的人群，併發症可能很嚴重，並且與嚴重的足部問題相關，包括顯著的截肢率。此外，踝關節疼痛是日本常見的肌肉骨骼壓力問題之一，在護理人員等某些職業群體中經常出現。隨著人口老化，這種情況推動了對先進骨科解決方案的需求，特別是在城市化和以醫療保健為重點的地區。在日本，膝骨關節炎影響 800 萬有症狀的人和 2500 萬有放射學證據的人，帶來了重大的經濟和醫療保健課題。到 2050 年，女性平均預期壽命預計將達到 90 歲，男性平均壽命將達到 84 歲，老化將進一步加劇對生活品質和醫療保健系統的影響。

本報告提供日本的足部·腳踝用設備市場相關調查，提供市場概要，以及各產品，手藝，各用途，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 日本的足部·腳踝設備市場預測，2018年～2032年

• 市場規模的分析與預測
• 市場佔有率分析與預測
• 市場地圖分析，2024年
  • 各產品
  • 手藝
  • 各用途
  • 各地區

第5章 需求供給分析

第6章 價值鏈分析

第7章 波特的五力分析

第8章 大環境分析

第9章 價格分析

第10章 市場動態

第11章 市場趨勢與發展

第12章 法規結構和革新

第13章 專利的形勢

第14章 案例研究

第15章 競爭情形

• 市場領導前五名的競爭矩陣
• 參與企業前五名的SWOT分析
• 市場參與企業首位9形勢
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Arthrex, Inc.
  • Johnson & Johnson Services, Inc.
  • Smith & Nephew plc.
  • Acumed LLC
  • DJO Global, Inc. (Enovis)
  • Paragon 28, Incorporated
  • Orthofix Medical Inc

第16章 策略性建議

第17章 諮詢方式和免責聲明

Japan foot and ankle devices market is projected to witness a CAGR of 8.55% during the forecast period FY2025-FY2032, growing from USD 224.37 million in FY2024 to USD 432.53 million in FY2032. Japan foot and ankle devices market is expected to keep growing robustly during the forecast period owing to an increasing geriatric population, increasing demand for minimally invasive surgery, and increasing advancements in healthcare technology.

The foot and ankle devices market in Japan is largely impacted by high prevalence rates of conditions that include diabetes-related complications, osteoporosis, and sports injuries. Diabetic peripheral neuropathies affect a considerable population, and the complications are likely to become severe and are related to severe foot issues, including having a notable rate of amputations. In addition, foot and ankle pain, which has been frequently reported among specific occupational groups, such as nurses, is one of the broader musculoskeletal stress issues in Japan. With an aging population, these conditions drive demand for advanced orthopedic solutions, especially in urbanized and healthcare-focused regions. In Japan, knee osteoarthritis affects 8 million symptomatic individuals and 25 million with radiographic evidence, creating significant economic and healthcare challenges. With life expectancy projected to reach 90 years for women and 84 years for men by 2050, the aging population exacerbates the impact on quality of life and healthcare systems.

Increasing Prevalence of Foot and Ankle Disorder Boosts Market Growth

The increasing prevalence of foot and ankle disorders is one of the most significant growth drivers in the Japan foot and ankle devices market. Common conditions, such as osteoarthritis, diabetic foot complications, fractures, and ligament injuries, are on the rise due to the increasing prevalence of chronic diseases and an aging population. Demographic changes, along with increasing cases of traumatic incidents, and obesity support the growth of the market. These disorders require specialized medical treatments in the form of implants, external fixation devices, and orthotics and, thus, are developing into an increasing market for advanced treatment solutions. Moreover, patient awareness and availability of orthopedic care are on the rise in urban and semi-urban regions, leading to sustained growth in the market.

For instance, in December 2024, Fujitsu Limited and iSurgery Co. Ltd. launched a bone health promotion project collaborating with Jikei University School of Medicine to improve early osteoporosis detection in Japan. This initiative uses iSurgery's AI-driven bone indicator software to analyze radiographs for bone health, offering a non-invasive method to assess osteoporosis risk.

Rising Awareness and Technological Advancements Drive Market Growth

Growing awareness about foot and ankle health and the pace of technological advancements are major growth drivers for Japan's foot and ankle devices market. Recognition of early diagnosis and treatment methods has driven higher adoption of orthopedic devices, especially in managing osteoarthritis, diabetic foot complications, and sports-related injuries. New technology with applications including 3D-printed implants, biodegradable material, and less invasive surgical techniques help treat patients better. These advancements, supported by growing accessibility to healthcare and initiatives for enhancing podiatric care, support the adoption of advanced devices for feet and ankles in urban and semi-urban regions of Japan.

For instance, in May 2024, OrthAlign, Inc. launched its Lantern handheld technology for knee arthroplasty in Japan, expanding its offerings to total, partial, and revision knee arthroplasty. Lantern provides personalized alignment with single-use, platform-agnostic technology for seamless integration into any operating room. The launch aims to strengthen OrthAlign's market position in Japan and drive growth for its partners.

Soft Tissue Orthopedic Devices Segment to Dominate the Foot and Ankle Devices Market

The soft tissue orthopedic devices segment is expected to capture the maximum market share in the foot and ankle devices market, led by an increasing incidence of sports-related injuries, growth in the prevalence of musculoskeletal disorders, and developments in minimally invasive surgical technologies. Advancements in invasive surgical techniques and the rising adoption of soft tissue repair solutions like tendon and ligament repair products result in improved patient outcomes and shorter recovery times, enhancing the dominance of this product segment. Also, the increasing demand for innovative biologics and synthetic materials to improve repair durability is supposed to boost market growth. For instance, in January 2023, Medacta International SA launched the NextAR Augmented Reality Surgical Platform in Japan. Medacta has successfully performed the first surgeries using its NextAR Augmented Reality Surgical Platform in Japan, following approval from the Ministry of Health, Labour, and Welfare. NextAR offers personalized augmented reality solutions for joint replacement and spine procedures, using real-time patient data to enhance surgical workflows. The platform is designed to improve surgical precision, with applications in knee, shoulder, and spine surgeries.

Osteoporosis Segment is Expected to Dominate the Japan Foot and Ankle Devices Market

The osteoporosis segment dominates the application category in the foot and ankle devices market in Japan because the country has a growing old population, coupled with an increased prevalence of bone diseases. Millions of individuals worldwide suffer from osteoporosis, especially postmenopausal women and geriatric males, which in turn results in an increase in demand for foot and ankle devices to treat fractures, deformities, and loss of bone density. This trend is compounded by the expected increase in the elderly population in Japan, which further increases the demand for sophisticated orthopedic solutions. Advances in implant materials, such as lightweight and biodegradable products, and better fixation techniques are also driving up the use of devices in this segment. The market leaders are now focusing on product development to cater to osteoporosis-related complications and solidify this segment at the top. For instance, in November 2024, Ortho Development Corporation, in partnership with Materialise NV, introduced BKS Total PSI, a patient-specific solution for total knee arthroplasty. This technology combines virtual visualization, pre-operative planning, and 3D-printed guides to enhance surgical precision, improve workflows, and reduce costs in surgical centers and hospitals. Ortho Development focuses on orthopedic solutions in the United States and Japan, with backing from Japan Medical Dynamic Marketing Inc.

Future Market Scenario (FY2025-FY2032F)

Japan is experiencing rapid demographic aging. As a result, orthopedic conditions such as osteoarthritis, fractures, and osteoporosis will highly increase, and thereby, a demand for foot and ankle devices will arise.

Innovations, such as 3D-printed implants, minimally invasive surgical techniques, and advanced fixation devices, will drive growth in the market due to improved efficacy and outcomes.

Rise in awareness about foot and ankle disorders and need for early interventions shall drive adoption of advanced treatment.

Increasing incidences of diabetes and its complications like diabetic foot ulcers will sustain the demand for devices designed particularly to treat these conditions.

Advances in Japan's healthcare facility along with a series of policy changes towards advanced technology medical care shall help accelerate market growth.

Market leaders shall launch innovative products and develop effective partnerships to have a maximum hold on the Japanese market.

A higher prevalence of sports injuries along with musculoskeletal conditions will also push the Japanese market toward upward growth.

Key Players Landscape and Outlook

Japan foot and ankle devices market is being catered to by major key players that have a global presence. Recent market developments include product launches, new treatment center setups, and strategic activities like mergers and acquisitions, driving growth and increasing competition.

For instance, in March 2024, Intellijoint Surgical Inc. received regulatory approval for its Intellijoint KNEE in Japan, marking its second orthopedic product in the country. Intellijoint KNEE provides real-time measurements for surgeons during total knee replacement and is compatible with all implant systems, enhancing its integration into existing surgical workflows and expanding its presence in the computer-assisted surgical navigation market. Following the success of Intellijoint HIP in Japan, the company continues to enhance surgical precision and patient outcomes globally.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Foot and Ankle Devices Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Bracing and Support Devices
    • 4.2.1.2. Joint Implant
    • 4.2.1.3. Orthopedic Fixation
    • 4.2.1.4. Soft Tissue Orthopedic Devices
    • 4.2.1.5. Prosthetics
  • 4.2.2. By Procedure
    • 4.2.2.1. Osteotomy
    • 4.2.2.2. Fracture Repair
    • 4.2.2.3. Fusion Procedures
    • 4.2.2.4. Others
  • 4.2.3. By Application
    • 4.2.3.1. Osteoarthritis
    • 4.2.3.2. Neurological Disorders
    • 4.2.3.3. Trauma
    • 4.2.3.4. Osteoporosis
    • 4.2.3.5. Hammertoe
    • 4.2.3.6. Rheumatoid Arthritis
    • 4.2.3.7. Others
  • 4.2.4. By Region
    • 4.2.4.1. North [Hokkaido and Tohoku]
    • 4.2.4.2. Central [Kanto and Chubu]
    • 4.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Procedure
  • 4.3.3. By Application
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Clinical Trials
• 12.2. Regulatory Approvals
• 12.3. Innovations

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 9 Market Players
  • 15.3.1. Stryker Corporation
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 15.3.2. Zimmer Biomet Holdings, Inc.
  • 15.3.3. Arthrex, Inc.
  • 15.3.4. Johnson & Johnson Services, Inc.
  • 15.3.5. Smith & Nephew plc.
  • 15.3.6. Acumed LLC
  • 15.3.7. DJO Global, Inc. (Enovis)
  • 15.3.8. Paragon 28, Incorporated
  • 15.3.9. Orthofix Medical Inc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Foot and Ankle Devices Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. Japan Foot and Ankle Devices Market Share (%), By Product, FY2018-FY2032F
• Figure 3. Japan Foot and Ankle Devices Market Share (%), By Procedure, FY2018-FY2032F
• Figure 4. Japan Foot and Ankle Devices Market Share (%), By Application, FY2018-FY2032F
• Figure 5. Japan Foot and Ankle Devices Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 7. By Procedure Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024